Trial

Phase 1 single center, randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study of EHP-101

Objective

Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers

Status

Completed | LEARN MORE

ClinicalTrials.gov Identifier: NCT03745001